Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Oxbryta (voxelotor by Quarter
Oxbryta (voxelotor — voluntarily withdrawn Sept 2024) [legacy through FY24] ($M) ($M)
Pfizer Oxbryta (voxelotor: $8M in Q4 2024, down 91.7% from a year earlier. No newer figure appears in the documents we track.
Where the Q4 2024 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2025-02-27) ↗
Reported in Form 10-K Segment Note.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Oxbryta (voxelotor — voluntarily withdrawn Sept 2024) [legacy through FY24] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2024 | Dec 31, 2024 | 8 | -91.7% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 29, 2024 | 17 | -80.0% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 92 | +19.5% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 84 | +18.3% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 96 | +31.5% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2023 | Oct 1, 2023 | 85 | – | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2023 | Jul 2, 2023 | 77 | – | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Apr 2, 2023 | 71 | – | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | 73 | – | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2022 | Oct 2, 2022 | 0 | – | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2022 | Jul 3, 2022 | 0 | – | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2022 | Apr 3, 2022 | 0 | – | Form 10-Q (filed 2023-05-10) ↗ |
Cite this data
StockData. (2026). Pfizer Oxbryta (voxelotor ($M), quarterly Q1 2022–Q4 2024 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/oxbryta-leg
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.